Actinic Keratosis
📧 Sign up to get email alerts when something new happens for Actinic Keratosis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2024-03-11FDA Approved: AMELUZ — Supplemental Application (Biofrontera Inc.)
FDA approved a supplemental application for AMELUZ (aminoLevulinic acid hydrochloride) from Biofrontera Inc., updating the labeling to refle…
-
FDA label_change · 2012-02-14FDA Approved: ZYCLARA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ZYCLARA (imiquimod) to update the labeling with new or expanded indications.
-
FDA label_change · 2011-07-15FDA Approved: ZYCLARA — Supplemental Application (Bausch Health US, LLC)
FDA records a supplemental application for ZYCLARA (imiquimod) from Bausch Health US, LLC, filed to update the product labeling.
-
FDA label_change · 2009-07-17FDA Approved: LEVULAN KERASTICK — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for LEVULAN KERASTICK (amino-levulinic acid hydrochloride) to update the labeling.